Medicine 401 Teaching Award Winners Announced

The winners of the 2015 Medicine 401 Teaching Awards were announced at an awards ceremony on May 27. Granted by the third-year medical students each year, the awards go to residents and attending physicians for their excellence in teaching on the wards at the Veterans Administration San Diego Healthcare System and the UC San Diego Medical Center in Hillcrest.

The winners:

VA Wards Resident Award: Dr. Tyler Woodell
Hillcrest Wards Resident Award: Dr. Michelle Pearlman

VA Wards Attending Award: Dr. Mara Zulauf
Hillcrest Wards Attending Award: Dr. Darcy Wooten

“There were many kind words of praise and admiration in the comments from the students who worked with Drs. Pearlman and Woodell,” said residency program director Simerjot Jassal, MD. “Congratulations to these outstanding doctors!”

The medical students’ comments included the following.

Dr. Michelle Pearlman

Dr. Michelle Pearlman

Of Michelle Pearlman, MD: … Really focused on teaching … worked hard during the rotation to make sure we were achieving our own goals and learning as much as possible … gave excellent feedback … made great teaching points during rounds … great example of professionalism … will make an excellent teacher … great role model … clear and detailed expectations … we knew exactly what to work on and how to succeed … one of the best residents with whom I have worked … gave frequent feedback enabling me to improve daily … strong leadership skills, a positive attitude, and a great work ethic … will make an amazing GI fellow and attending.

Dr. Pearlman has matched to a fellowship program in gastroenterology at University of Texas Southwestern Medical Center in Dallas.

Dr. Tyler Woodell

Dr. Tyler Woodell

Of Tyler Woodell, MD: Always made it a priority to have a teaching point every day … always willing to make sure all of our questions were answered and that we were engaged in patient care … went out of his way to make sure we had a good learning experience … an exceptional model physician who I would recommend to any student as a preceptor and any patient as a doctor … focused on making sure that we learned as much as possible … carved out time to talk through our assessment and plans with us … took time on rounds to talk through key issues with us …both a fantastic role model for compassionate patient care and bedside manner as well as an engaging teacher … clearly loved to teach … not only an outstanding teacher, but also very compassionate with patients.

Dr. Woodell has matched to a fellowship program in nephrology at Oregon Health & Science University.

Dr. Sheila Crowe Selected as Vice President of the American Gastroenterological Association

An Announcement from Dr. William J. Sandborn
Professor and Chief, Division of Gastroenterology –

Dr. William Sandborn

Dr. William Sandborn

It is with great pleasure that I share with you that Dr. Sheila Crowe has been selected as Vice President of the American Gastroenterological Association (AGA).

In this role, she will begin a four-year term of service to the AGA, transitioning yearly from Vice President to President Elect to President and finally to Past President and Chair of the AGA Foundation.

Dr. Sheila E. Crowe

Dr. Sheila E. Crowe, Professor of Medicine and Director of Research in the Division of Gastroenterology.

This is perhaps the highest honor that a physician in our specialty can receive. It is a tremendous honor for Dr. Crowe, and for our entire Division.

I am so proud to have Dr. Crowe in our Division. Please join me in congratulating her on this accomplishment.

Best regards,

William J. Sandborn, MD
Professor of Medicine and Adjunct Professor of Surgery
Chief, Division of Gastroenterology
Director, Inflammatory Bowel Disease Center
University of California, San Diego
and UC San Diego Health System

Thomas Savides, MD, Named Chief Experience Officer for UC San Diego Health System

Thomas Savides, MD, has been named as the first Chief Experience Officer at UC San Diego Health System. In the newly created role, Savides will be responsible for the strategy, leadership and implementation of the plan to improve the total health care experience of patients, families, providers and staff. … Read the full story from the UC San Diego Newsroom

Dr. Rebecca Sell Receives ATS Young Investigator Award

Dr. Rebecca Sell

Dr. Rebecca Sell

Rebecca Sell, MD, associate director of the Internal Medicine Residency Program and assistant professor of medicine in the Division of Pulmonary and Critical Care Medicine, won an American Thoracic Society (ATS) 2014 Young Investigator Award for her presentation at the annual meeting of the Asian Pacific Society of Respirology (APSR) in Bali, Indonesia, November 13-16, 2014.

Her presentation was titled, “Difference in Outcomes between Senior Physician and Medicine Resident-led Code Blues.”

Dr. Sell was a chief medical resident in the UC San Diego Internal Medicine Residency Training Program in 2006-2007.

Dr. Rebecca Sell receiving award at 2014 APRS meeting.

Dr. Sell receiving the award. Photo by Atul Malhotra, MD.

On the APSR 2014 program faculty was Atul Malhotra, MD, Kenneth M. Moser Professor of Medicine, director of sleep medicine and chief of the UC San Diego Division of Pulmonary and Critical Care Medicine.

Dr. Malhotra, who received an ATS Young Investigator award in 2005, will serve as president of the ATS in 2015-2016.

Dr. Catriona Jamieson Announced as Inaugural Chief of New Division of Regenerative Medicine

Announced today by Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

Catriona H. M. Jamieson, MD, PhD

Catriona Jamieson, MD, PhD

Please join me in officially welcoming Catriona Jamieson, MD, PhD, as the inaugural chief of the new Division of Regenerative Medicine. The Department of Medicine is delighted to announce the inception of the Division of Regenerative Medicine and we enthusiastically support Dr. Jamieson’s talent and vision for this innovative endeavor.

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

Dr. Jamieson joined the UC San Diego faculty in 2005 and is an associate professor of Medicine in the Division of Hematology-Oncology. She has proven her leadership skills, expertise and effectiveness in her current positions as director of the Stem Cell Research Program at Moores Cancer Center, co-leader of the Hematologic Malignancies Program, hematology team leader, co-director of the UC San Diego Stem Cell Training Grant, coordinating course director of the Interdisciplinary Stem Cell course, and a co-director of the new Sanford Stem Cell Clinical Center.

Dr. Jamieson received her medical and doctorate degrees from the University of British Columbia. She completed her residency and clinical fellowships in bone marrow transplantation and hematology, as well as her postdoctoral research fellowship in the laboratory of Professor Irving Weissman at Stanford.

As a physician-scientist, Dr. Jamieson specializes in leukemia and myeloproliferative neoplasms, which are a family of uncommon, but not rare, degenerative disorders in which the body overproduces blood cells. These disorders can cause blood clotting which can lead to heart attack, stroke, and other life-threatening complications including transformation to acute leukemia. Dr. Jamieson’s research focuses on the mutant stem cells and progenitor cells in myeloproliferative neoplasms, which can give rise to cancer stem cells. Her stem-cell research studies have taken a substantial leap from identifying a promising treatment in the laboratory to completing the first clinical trial targeting cancer stem cells in humans. Her discoveries in myeloproliferative neoplasms are now being brought together with a drug development track of a regional pharmaceutical company.

Please join me in giving your enthusiastic support to Dr. Jamieson in her new leadership role as the inaugural chief of the Division of Regenerative Medicine here at UC San Diego. This is a unique and exciting opportunity to make UC San Diego a key hub for the rapid translation of stem cell discoveries to the clinic.

John Adamson Honored with American Society of Hematology Mentor Award for Basic Science

Dr.  John AdamsonThis week at its annual meeting in New Orleans, the American Society of Hematology (ASH) is presenting Dr. John W. Adamson with its 2013 Mentor Award for Basic Science.

John W. Adamson, MD, is clinical professor of medicine in the Division of Hematology-Oncology and associate director of the Hematology-Oncology Fellowship Training Program in the University of California, San Diego School of Medicine.

The ASH mentoring awards recognize hematologists who have had a significant, positive impact on their mentees’ careers and, through their mentees, have advanced research and patient care in the field of hematology.

The award cites Adamson for his passion for teaching the interrelationship between clinical medicine and biomedical science and the importance of granting early-career hematologists with protected time to develop their scientific skills.

Dr. Adamson has been particularly exceptional at forging bonds among early-career investigators with similar interests and has been an advocate for the advancement of women in hematology.

Several of his mentees have become leading experts in the field, and many have assumed leadership roles in the greater hematology research community.

Adamson is a past president of the American Society of Hematology and was editor of its official journal, Blood, from 1983 to 1987.

More Information:

Read the American Society of Hematology press release

Bruce Zuraw, MD, Is New Chief of Rheumatology, Allergy & Immunology Division

Announcement

From Wolfgang H. Dillmann, MD
Helen M. Ranney Distinguished Professor
Chair of the Department of Medicine

I am pleased to announce that an internal review committee has selected Dr. Bruce Zuraw as the new chief of the Division of Rheumatology, Allergy & Immunology in the Department of Medicine. He is also inaugural holder of the US Hereditary Angioedema Association (HAEA) Endowed Chair.

I would like to express my gratitude to Dr. Robert Terkeltaub, who accepted the role of interim division chief after Dr. Gary Firestein stepped down in June 2010. In leading the Division of Rheumatology, Allergy & Immunology for the past three years, Dr. Terkeltaub has done an important service for the division and the department.

Bruce L. Zuraw, MD, professor of medicine, is Director of the Section of Allergy and Immunology at the Veterans Affairs San Diego Healthcare System and head of the Allergy & Immunology section of the Division of Rheumatology, Allergy & Immunology at UC San Diego. He directs the Allergy and Immunology Fellowship Program.

Dr. Zuraw is a highly respected clinician, researcher and thought leader in the field of allergy and immunology and an internationally recognized expert in hereditary angioedema. He chairs the Medical Advisory Board of the US Hereditary Angioedema Association (HAEA) and will direct the newly established US HAEA Angioedema Center at UC San Diego.

Dr. Zuraw joined the faculty of the UC San Diego School of Medicine in 2004 after many years as a fellow, clinician, researcher and leader at Scripps Clinic & Research Foundation and The Scripps Research Institute.

He was born in Brookline, Massachusetts, and received his undergraduate degree in biology from Carleton College in Northfield, Minnesota, in 1972. He earned his M.D. degree and completed his internal medicine residency training at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois.

Dr. Zuraw received his fellowship training and established his research and clinical career in allergy and immunology at Scripps Clinic and Research Foundation and The Scripps Research Institute in La Jolla. There, he rose to the rank of associate professor in the Department of Molecular and Experimental Medicine and held a number of leadership positions, including director of the Allergy & Immunology Fellowship Training Program, associate director of the General Clinical Research Center and director of research for the Scripps Internal Medicine Residency Program.

Dr. Zuraw has been very active in service to the University and the Veterans Affairs San Diego Healthcare System. In addition to his divisional and educational program leadership positions, he has chaired the VA Research Space Committee and served on the DOMCAP Committee. He is currently on the VA Research Information Security Subcommittee and the Intern Selection Committee of the UCSD Internal Medicine Residency Program.

In his research, Dr. Zuraw is a highly respected investigator in the area of allergic inflammation in humans, with particular attention to hereditary angioedema, and the mechanism of action of glucocorticoids. He is principal investigator of a number of basic and clinical research projects including major projects funded by the National Institutes of Health, the Department of Defense, and the VA Merit program. He has published more than 120 peer-reviewed articles and nearly 50 invited reviews and book chapters.

Please join me in giving your enthusiastic support to Dr. Bruce Zuraw in his new position of leadership in the Department of Medicine.

Scott M. Lippman, MD, Named New Director of UC San Diego Moores Cancer Center

Scott M. Lippman, MD, chair of Thoracic/Head and Neck Medical Oncology at The University of Texas (UT) MD Anderson Cancer Center, has accepted the position of director of Moores Cancer Center at the University of California, San Diego, beginning May 1, 2012…. Read the full story from the UCSD Newsroom

Dr. Greg Maynard: Two New Leadership Roles in Hospital Quality Improvement

Directing QI Initiatives for UC San Diego and the Society of Hospital Medicine


Dr. Greg Maynard Accepting new leadership positions in hospital quality improvement with UC San Diego and the Society of Hospital Medicine (SHM), Dr. Greg Maynard has stepped down as Hospital Medicine division chief effective July 1.

He will direct the UC San Diego Center for Innovation and Improvement Science (CIIS) and serve as Senior Vice President of the Society of Hospital Medicine’s new Center for Healthcare Improvement and Innovation (CHII).  |  Read the SHM press release >

“I’m excited about the opportunities for collaboration, improvement, and innovation afforded by each of these positions, as well as the potential synergy between them,” said Maynard.

A member of the UC San Diego Department of Medicine faculty since 2003, Maynard was the founding chief of the Division of Hospital Medicine when it was established in 2005.

“As division chief, Greg Maynard has developed one of the most respected and effective hospitalist programs in the country,” said Department of Medicine Interim Chair Wolfgang H. Dillmann, MD.

“I have no doubt that UC San Diego Health System and the Society of Hospital Medicine will make important advances in hospital quality and patient safety through his leadership.”

DrGregSeymannLongtime UC San Diego hospitalist Gregory B. Seymann, MD, SFHM, Health Sciences Clinical Professor, is the new Hospital Medicine division chief. For the past year, he has served as associate division chief with Dr. Bryan Huang.

“The Division of Hospital Medicine has benefited greatly from Dr. Maynard’s leadership.” Seymann said. “I will work hard during this transition to maintain the excellent patient care, teaching, and systems improvement efforts that our division has championed.”

Dr. Bryan Huang

Health Sciences Assistant Clinical Professor Bryan Huang, MD, will continue in his role as associate division chief.

Maynard will carry out his SHM duties largely from San Diego, with periodic visits to SHM headquarters in Philadelphia.

With a part-time appointment in Hospital Medicine, he will continue to be involved in the division’s clinical, teaching, and quality improvement activities.

He will also continue as chair of the UC San Diego Health System Patient Safety Committee.

Leading The Center in the Society of Hospital Medicine

The Society of Hospital Medicine (SHM) is the primary professional medical society for hospitalists. Its Center for Healthcare Improvement and Innovation, known as The Center, is a new division that gathers all quality improvement initiatives under Maynard’s direction.   |   Read the SHM press release >

Maynard has played influential roles in developing these initiatives. He has served as a leader in SHM collaboratives on venous thromboembolism (VTE) prevention, glycemic control, and transitions of care for older adults in the hospital.

A founder of the SHM’s Mentored Implementation Program, he has guided numerous hospital medicine programs through quality improvement processes that mirror what he and his colleagues have done at UC San Diego.

Now, as Senior Vice President of The Center, Maynard will oversee all QI initiatives and assist the SHM in designing its strategies for supporting and expanding its healthcare quality improvement efforts.

The Center provides a suite of QI tools and resources for hospitalists. Online collaboration programs offer expert guidance in VTE prevention, glycemic control, and transitions of care.

Through The Center, hospitalists can obtain mentored implementation programs, communicate with other QI program directors via a collaborative network, and access an online QI data repository.

The Agency for Healthcare Research and Quality recently recognized The Center as a Patient Safety Organization, which makes it possible for medical centers to submit protected health information to the SHM for analysis of patient safety events without violating HIPAA guidelines.

Leading the UC San Diego Center for Innovation and Improvement Science

UC San Diego Medical Center in Hillcrest The Center for Innovation and Improvement Science is a new entity that conducts quality improvement efforts in collaboration with UC San Diego Health System management, the Performance Improvement and Patient Safety Office, the Clinical and Translational Research Institute, and the Division of Biomedical Informatics.

As director of the CIIS, Maynard is leading UC San Diego’s efforts to address local and regional quality improvement goals:

  • Accelerating inpatient quality and safety initiatives and developing tools to assess their progress
  • Fostering QI skills in UC San Diego personnel and their collaborators and disseminating their successful QI tools through mentorship, consultation, and publication
  • Reviewing new technologies and fostering new research programs

One of the specific goals of the CIIS is to help other local and regional medical centers improve their quality of care, particularly in VTE prevention, glycemic control, anticoagulation management, and transitions of care.

Another goal is to disseminate UC San Diego’s findings and achievements, establishing UC San Diego more firmly as an innovative center and a leader in hospital quality and patient safety.

About Dr. Maynard

Dr. Greg MaynardGregory A. Maynard, MD, MSc, SFHM, Health Sciences Clinical Professor, has led the development of patient safety and hospital quality improvement protocols that have gone on to widespread implementation through the Society of Hospital Medicine, the Agency for Healthcare Research and Quality, the Institute for Healthcare Improvement, and the American Society of Health-System Pharmacists.

For their work in venous thromboembolism (VTE) prevention, Maynard and his colleagues received the SHM Team Approaches in Quality Improvement Award in 2008 and the Venous Disease Coalition’s Venous Research Award for Quality Improvement and Implementation of Best Practices in 2009.

Maynard received his MD degree at the University of Illinois and completed his residency and chief residency in Internal Medicine at Good Samaritan Regional Medical Center in Phoenix, Arizona.

Thereafter, he directed the Good Samaritan Hospital Medicine program and served as Senior Associate Director of the Internal Medicine Residency Program.

He earned his MSc in Clinical Research Design and Biostatistics from the University of Michigan in 1993.

Since Maynard came to UC San Diego in 2003, the Hospital Medicine program has expanded from 4 faculty members covering Thornton Hospital to 30 faculty hospitalists covering both Thornton Hospital and the UC San Diego Medical Center in Hillcrest.

Maynard has served as chair of the Inpatient Glycemic Control Committee, the Patient Discharge Process Improvement /Transitions of Care Committee, and the Patient Safety Committee. He has been leader of the VTE Management Task Force and co-leader of the Inpatient Osteoporosis Identification and Management Task Force.

The American College of Physicians named Maynard a Top Hospitalist in the United States in November 2008. This year, he received the UC San Diego School of Medicine’s Leadership and Innovation in Patient-Centered Systems Award.

About Dr. Seymann

Dr. Greg SeymannGregory B. Seymann, MD, SFHM, received his MD degree from UCLA in 1994 and completed his residency training in internal medicine at UC San Diego in 1997. Upon his graduation, he joined the UC San Diego Department of Medicine faculty as an assistant professor.

Seymann helped to found the original group of hospitalists at UC San Diego in 1998.

Seymann’s clinical and research interests are in community-acquired and healthcare-associated pneumonia, performance measurement for hospitals and physicians, systems-based quality improvement, and perioperative consult medicine.

In 2008, the San Diego County Medical Society and San Diego Magazine named Seymann to the “San Diego’s Top Doctors” list. In the same year, graduating housestaff honored him with their annual teaching award.

This year, he received the Medicine 401 Excellence in Teaching Award.

In the Society of Hospital Medicine, Seymann chairs the Academic Practice and Promotions Task Force and is a member of the Academic Hospitalist Committee, the Performance and Standards Committee, and the Ethics QI Research Subcommittee.

He is a member of the UC San Diego Patient Safety Committee. In the Department of Medicine, he is a member of the Committee on Advancement and Promotions, the Peer Review Committee, and the Executive Committee. He chairs the Division of Hospital Medicine Peer Review Committee.

Seymann is a member of the UC San Diego ORYX Core Measures Team for Community Acquired Pneumonia. ORYX is an initiative of the Joint Commission for Accreditation of Healthcare Organizations.

About Dr. Huang

Dr. Bryan HuangBryan Huang, MD, Health Sciences Assistant Clinical Professor, received his MD degree from UC San Francisco. He has been a member of the Hospital Medicine faculty since his graduation from internal medicine residency training at Stanford University in 2006.

Huang has special interest in the areas of prevention and management of delirium, prevention of falls, transitions of care, VTE prevention, and treatment of pneumonia.

He has completed additional training in quality improvement through the mini-advanced training program offered by Intermountain Healthcare in Salt Lake City, as well as the SHM Leadership Academy.

He served as the Thornton site director for the Core Clerkship in Internal Medicine in the School of Medicine until this June, and will continue to serve on the Medicine 401 course committee.

Huang served on the SHM Early Career Hospitalists committee from 2007 to 2010.

Together with Dr. Greg Seymann, he has served as associate division chief of Hospital Medicine for the past year. His responsibilities have included workflow redesign, scheduling, budgeting, recruitment, and working with the Internal Medicine Residency Program.

Dr. Gary Firestein Honored with 2010 Jane Wyman Humanitarian Award

Dr. Gary Firestein

Gary S. Firestein, MD, Professor of Medicine, Dean and Associate Vice Chancellor of Translational Medicine and Director of the Clinical and Translational Research Institute at the University of California, San Diego School of Medicine, has been named the 2010 recipient of the prestigious Jane Wyman Humanitarian Award from the Arthritis Foundation, Pacific Region.

This award recognizes Firestein’s “affiliation with the Arthritis Foundation and its mission, and his extraordinary leadership in rheumatology and philanthropy in the community.”

The award will be presented at the foundation’s Commitment to a Cure Gala at the Beverly Wilshire Hotel in Beverly Hills on November 1. Past recipients of the Jane Wyman Humanitarian Award have included Victoria Principal; Sarah Purcell; Kathy Ireland; William Friedkin, Academy Award winning director of “The French Connection” and “The Exorcist;” Los Angeles Dodger Manager, Joe Torre; and Academy Award winning legend Al Pacino.

Firestein is considered the leading expert in the field of rheumatoid arthritis, a disabling and chronic disease affecting some 2.1 million Americans. His research focuses on the pathogenesis of rheumatoid arthritis and mechanisms of inflammation, and his studies have played a pivotal role in the development of the highly effective drugs to treat this crippling disease.